Phenazone (INN), phenazon, antipyrine (USAN), or analgesine is an analgesic and antipyretic. It was first synthesized by Ludwig Knorr in 1883.[1] It is formed by reducing diortho- dinitrodiphenyl with sodium amalgam and methyl alcohol, or by heating diphenylene-ortho-dihydrazine with hydrochloric acid to 150 °C. It crystallizes in needles which melt at 156 °C. Potassium permanganate oxidizes it to pyridazine tetracarboxylic acid. Phenazone has an elimination half life of about 12 hours. [2]
Adverse effects[edit]
Possible adverse effects include:[citation needed]
See also[edit]
References[edit]
|
|
|
Opioids
See also: Opioids template |
|
Opium & alkaloids thereof
|
|
|
|
Semi-synthetic opium
derivatives
|
|
|
|
Synthetic opioids
|
|
|
|
| Pyrazolones |
|
|
| Cannabinoids |
|
|
| Anilides |
|
|
Non-steroidal
anti-inflammatories
See also: NSAIDs template |
|
Propionic acid class
|
|
|
|
Oxicam class
|
|
|
|
Acetic acid class
|
|
|
|
|
|
|
|
Anthranilic acid
(fenamate) class
|
|
|
|
|
|
|
|
Atypical, adjuvant and potentiators,
metabolic agents and miscellaneous |
|
|
|
|
|
|
|
|